Ranbaxy Pharmaceuticals is recalling a popular generic brand of a cholesterol medication.No reason is being given, but the company is asking people who take Atorvastatin, a generic version of Pfizers' ...

(Reuters) - Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay sales of less ...

NEW JERSEY (KTLA) — A generic form of the cholesterol lowering drug Lipitor has been recalled after some batches were found to contain pieces of glass. Indian ...

Drug prices almost always fall after a manufacturer’s patent expires and generics hit the market. But with its blockbuster cholesterol-fighting drug Lipitor going off-patent this week, drug maker ...

TRENTON, N.J. (AP) – Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string ...

In a first-of-its-kind marketing move, Lipitor-manufacturer Pfizer wants to do all it can to make sure heart patients continue to buy their prescription brand. They're offering discount incentives to ...

Pfizer Inc. and India’s Ranbaxy Laboratories Ltd. agreed to keep copies of the cholesterol pill Lipitor off the U.S. market an extra 20 months, protecting $12 billion in sales for Pfizer. Under the ...

WASHINGTON, June 13, 2013 /PRNewswire-USNewswire/ -- Today, AARP's Public Policy Institute released a new Rx Price Watch report examining efforts by Pfizer to reduce the impact of generic competition ...

India's largest maker of generic drugs won approval Wednesday to sell a generic version of cholesterol blockbuster Lipitor. The world's top-selling drug ever lost U.S. patent protection earlier in the ...

LOS ANGELES (CBSLA.com) — Several doses of a generic version of Lipitor have been recalled because some batches might contain small glass particles. Indian drug maker Ranbaxy, which manufactures the ...